Effect of Low-level Laser Therapy on Type II Controlled Diabetic Patients After Dental Implant Insertion
- Conditions
- Low-level Laser TherapyT2DM (Type 2 Diabetes Mellitus)Bone Density Increased
- Interventions
- Radiation: low-level laser therapy (LLLT)
- Registration Number
- NCT05279911
- Lead Sponsor
- Sinai University
- Brief Summary
This study aimed therefore to evaluate bone density (BD) and OPG levels in the peri-implant crevicular fluid (PICF) in lased controlled type II Diabetes Mellitus (T2DM) patients versus non-lased T2DM patients. 40 T2DM patients were included in this study. Implants were randomly inserted in 20 non-lased T2DM patients (Control) and 20 lased T2DM patients (Intervention). BD and OPG levels in the PICF were assessed in both groups at the follow up points.
- Detailed Description
Background and objectives: Use of low-level laser therapy (LLLT) with dental implants has been suggested to improve bone quality during osseointegration. However, there is a lack of evidence about its influence on dental implants in diabetic patients. Osteoprotegrin (OPG) levels was reported as a biomarker for bone turnover to distinguish implant prognosis. This study aimed therefore to evaluate bone density (BD) and OPG levels in the peri-implant crevicular fluid (PICF) in lased controlled type II Diabetes Mellitus (T2DM) patients versus non-lased T2DM patients. Methods: 40 T2DM patients were included in this study. Implants were randomly inserted in 20 non-lased T2DM patients (Control) and 20 lased T2DM patients (Intervention). BD and OPG levels in the PICF were assessed in both groups at the follow up points.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- None of the participants had other major illnesses or severe diabetic complications.
- A detailed medical history of each subject was obtained according to the detailed questionnaire of the modified Cornell Medical Index [22].
- Diabetic control was measured by glycosylated hemoglobin A1c (HbA1c) of blood samples, patients had relatively stable glycemic control, as demonstrated by a difference not exceeding 1% in at least two HbA1c assays over the previous 6 months.
- Participants with partial edentulous posterior mandibular region with bone density ranging between D2 and D3, also having adjacent tooth with healthy periodontium were selected.
- Any uncontrolled systemic diseases that prevent surgery for dental implant placement; (b) Need for guided bone regeneration or sinus lift for implant placement, and (c) History of radiation therapy in head and neck.
- Pregnant women, smokers and patients with para-functional habits, psychological problems or in-cooperated patients were also excluded.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Low level laser therapy low-level laser therapy (LLLT) Implant were randomly inserted in 20 lased T2DM patients (Intervention)
- Primary Outcome Measures
Name Time Method Bone density Month 4 Bone density was evaluated in the peri-implant crevicular fluid (PICF) in lased controlled type II Diabetes Mellitus (T2DM) patients versus non-lased T2DM patients.
Osteoprotegrin (OPG) level Month 4 Osteoprotegrin (OPG) level was evaluated in the peri-implant crevicular fluid (PICF) in lased controlled type II Diabetes Mellitus (T2DM) patients versus non-lased T2DM patients.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (5)
Faculty of Dental Medicine for Girls, Al-Azhar University
🇪🇬Cairo, Egypt
Misr University for Science and Technology (MUST)
🇪🇬Cairo, Egypt
Delta University of Science and Technology
🇪🇬Gamasa, Egypt
Misr International University
🇪🇬Cairo, Egypt
Sinai University
🇪🇬El-Arish, Egypt